BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kovacs AK, Atlasz T, Werling D, Szabo E, Reglodi D, Toth GK. Stability Test of PACAP in Eye Drops. J Mol Neurosci 2021;71:1567-74. [PMID: 32323126 DOI: 10.1007/s12031-020-01532-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kiss P, Farkas J, Kovacs K, Gaal V, Biro Z, Szabo A, Atlasz T, Bosnyak I, Toth G, Tamas A, Reglodi D. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) in corneal epithelial regeneration and signal transduction in rats. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10405-1] [Reference Citation Analysis]
2 Pöstyéni E, Ganczer A, Kovács-Valasek A, Gabriel R. Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice. Front Pharmacol 2021;12:808315. [PMID: 35095518 DOI: 10.3389/fphar.2021.808315] [Reference Citation Analysis]
3 Hirabayashi T, Shibato J, Kimura A, Yamashita M, Takenoya F, Shioda S. Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease. Int J Mol Sci 2022;23:664. [PMID: 35054857 DOI: 10.3390/ijms23020664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kiss P, Banki E, Gaszner B, Nagy D, Helyes Z, Pal E, Reman G, Toth G, Tamas A, Reglodi D. Protective Effects of PACAP in a Rat Model of Diabetic Neuropathy. Int J Mol Sci 2021;22:10691. [PMID: 34639032 DOI: 10.3390/ijms221910691] [Reference Citation Analysis]
5 Phetsanthad A, Vu NQ, Yu Q, Buchberger AR, Chen Z, Keller C, Li L. Recent advances in mass spectrometry analysis of neuropeptides. Mass Spectrom Rev 2021;:e21734. [PMID: 34558119 DOI: 10.1002/mas.21734] [Reference Citation Analysis]
6 D’amico AG, Maugeri G, Musumeci G, Reglodi D, D’agata V. PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy. J Mol Neurosci 2021;71:1525-35. [DOI: 10.1007/s12031-020-01769-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]